{"schema_version":"1","generated_at":"2026-11-06T07:00:56.666Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ryan-holstead","json_url":"https://www.findmykol.com/kol/ryan-holstead/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ryan-holstead","name":"Ryan Holstead","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Massachusetts Chan Medical School","institution_url":"https://www.findmykol.com/institution/university-of-massachusetts-chan-medical-school","city":"Worcester","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1952753873","orcid":"0000-0002-6378-9585","openalex":"A5018449353"},"summary":"Ryan Holstead is an Oncology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 20 publications with 291 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":20,"cited_by_count":291,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":23,"program_years":{"first":2021,"last":null},"rows_total":31,"shown":3,"withheld":28,"rows":[{"payer":"Galvanize Therapeutics, Inc","program_year":2024,"amount_usd":167.1,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952753873"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2023,"amount_usd":89.49,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952753873"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2023,"amount_usd":34.75,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952753873"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952753873","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":42.4,"classes_total":6,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":14.3,"drugs":[{"name":"Ondansetron Hcl","share_pct":71.4},{"name":"Ondansetron Odt","share_pct":28.6}],"max_beneficiaries":33},{"class":"Opioid Agonist","setting":"prescribed","share_pct":7.5,"drugs":[{"name":"Loperamide","share_pct":100}],"max_beneficiaries":20}]},{"area":"Nervous system","share_pct":39,"classes_total":2,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":22.7,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":64},{"class":"Opioid Agonist","setting":"prescribed","share_pct":16.3,"drugs":[{"name":"Oxycodone Hcl","share_pct":65.3},{"name":"Oxycodone-Acetaminophen","share_pct":18.1},{"name":"Tramadol Hcl","share_pct":16.7}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":7.3,"classes_total":2,"classes":[{"class":"Antiarrhythmic","setting":"prescribed","share_pct":4.5,"drugs":[{"name":"Lidocaine-Prilocaine","share_pct":100}],"max_beneficiaries":15},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":2.7,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":56.2,"facility_pct":43.8},"source":"medicare"},"publications":{"total":20,"shown":5,"withheld":15,"matched_by":"OpenAlex author record","recent":[{"title":"Survival outcomes in localized pancreatic cancer treated with neoadjuvant chemotherapy (NAC).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.683","status":"verified"},{"title":"Utility of Large Language Models to Produce a Patient-Friendly Summary From Oncology Consultations","year":2024,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op.24.00057","status":"verified"},{"title":"Global interest in podcasts designed for medical oncology trainees.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.9019","status":"verified"},{"title":"No Association Between BMI and Immunotoxicity or Clinical Outcomes for Immune Checkpoint Inhibitors","year":2022,"journal":"Immunotherapy","source_url":"https://doi.org/10.2217/imt-2021-0250","status":"verified"},{"title":"Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases","year":2021,"journal":"Journal of Immunotherapy","source_url":"https://doi.org/10.1097/cji.0000000000000377","status":"verified"}],"source":"works"},"contact":{"address_1":"55 LAKE AVE N","city":"Worcester","state":"MA","zip":"016550002","phone":"508-334-3550","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1952753873","source":"identity"},"similar":[{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"Kimberly Yonkers","slug":"kimberly-yonkers","institution":"University of Massachusetts Chan Medical School","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/kimberly-yonkers","json_url":"https://www.findmykol.com/kol/kimberly-yonkers/profile.json"},{"name":"Richard Irwin","slug":"richard-irwin","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/richard-irwin","json_url":"https://www.findmykol.com/kol/richard-irwin/profile.json"},{"name":"Craig Lilly","slug":"craig-lilly","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/craig-lilly","json_url":"https://www.findmykol.com/kol/craig-lilly/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":28,"publications":15}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-08-22","provider_certified":"2023-08-22","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}